MedPath

QUIXIL

QUIXIL

Approved
DIN Number

02283980

Drug Class

Human

Market Date

N/A

Company
HC

OMRIX BIOPHARMACEUTICALS LTD

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02283980
AIG Number0351655001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BC30 COMBINATIONS
Product Specifications
Dosage FormKit ,  Solution
Route of AdministrationTopical
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (3)

CALCIUM CHLORIDEActive
Strength: 6.2 MG / ML
Monograph: CALCIUM CHLORIDE
FIBRINOGEN (HUMAN)Active
Strength: 60.0 MG / ML
Monograph: FIBRINOGEN (HUMAN)
THROMBIN (HUMAN)Active
Strength: 1200 UNIT / ML
Monograph: THROMBIN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.